Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Study of Anlotinib After Lenvatinib in Patients With Hepatocellular Carcinoma [Phase 2]
Phase 2 trial update on anlotinib after lenvatinib in hepatocellular carcinoma patients; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-03-25Clinical Trial Update: Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC [Phase 3]
Phase 3 trial evaluating sorafenib plus TACE versus sorafenib alone as postoperative adjuvant treatment for resectable primary advanced hepa…
-
CLINICAL_TRIALS trial_result · 2020-03-25Clinical Trial Update: Postoperative Antimicrobial Prophylaxis Versus Placebo for Infection Prevention in HCC After Liver Resection [Phase 3]
Phase 3 clinical trial evaluating postoperative antimicrobial prophylaxis versus placebo for infection prevention in hepatocellular carcinom…
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation [Phase 3]
A Phase 3 clinical trial evaluating relenvatinib for treating recurrence of hepatocellular carcinoma after liver transplantation is listed, …
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus [Phase 2, Phase 3]
Clinical trial update for lenvatinib after liver transplantation in patients with hepatocellular carcinoma and portal vein tumor thrombus (P…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: Stereotactic Body Radiotherapy for Liver Tumors [NA]
Clinical trial update on stereotactic body radiotherapy for liver tumors has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240) [Phase 3]
Phase 3 trial of pembrolizumab vs best supportive care in previously treated advanced hepatocellular carcinoma completed; results posted in …
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of HCC [Phase 2]
Phase 2 trial evaluating a PD-1 monoclonal antibody, lenvatinib, and transarterial chemoembolization (TACE) for non-resectable hepatocellula…
-
CLINICAL_TRIALS trial_result · 2020-02-11Clinical Trial Update: Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection [Phase 3]
Phase 3 clinical trial evaluating sorafenib for hepatocellular carcinoma with microvascular invasion after radical resection has been termin…
-
CLINICAL_TRIALS trial_result · 2020-02-11Clinical Trial Update: Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma [Phase 3]
Phase 3 trial evaluating transcatheter arterial chemoembolization combined with sorafenib in unresectable hepatocellular carcinoma has compl…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma [Phase 4]
A Phase 4 clinical trial investigating the combination of sorafenib with TACE in hepatocellular carcinoma guided by GALNT14 genotype.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients [Phase 1, Phase 2]
Phase 1/2 trial update for IMA970A plus CV8102 in very early to intermediate hepatocellular carcinoma has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Efficacy and Safety of Lenvatinib as a Conversion Therapy for HCC [Phase 2]
Phase 2 clinical trial assessing lenvatinib as a conversion therapy for hepatocellular carcinoma (HCC) with efficacy and safety outcomes.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects [Phase 2]
Phase 2 trial update of an individualized anti-cancer vaccine in adults with advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery [NA]
A completed clinical trial evaluating stereotactic body radiation therapy for patients with unresectable hepatocellular carcinoma, with resu…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Sorafenib Combined With Arsenical in Treating Patients With Recurrent HCC After Liver Transplantation [Phase 2]
Phase 2 clinical trial evaluating sorafenib plus arsenic-based treatment for recurrent hepatocellular carcinoma after liver transplantation.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Efficacy and Safety of Lenvatinib as an Adjuvant Therapy for Hepatocellular Carcinoma [Phase 2]
Phase 2 trial update evaluating lenvatinib as adjuvant therapy for hepatocellular carcinoma, focusing on efficacy and safety outcomes.
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: Adjuvant Therapies for Patients With HCC and MVI [Phase 3]
Phase 3 clinical trial update on adjuvant therapies for hepatocellular carcinoma with microvascular invasion (HCC with MVI).
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma [Phase 2, Phase 3]
Clinical trial update reporting efficacy and safety of donafenib in advanced hepatocellular carcinoma across Phase 2 and Phase 3 (completed)…
-
CLINICAL_TRIALS withdrawal · 2020-01-09Clinical Trial Update: Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection [Phase 2, Phase 3]
A clinical trial evaluating lenvatinib plus nivolumab vs lenvatinib for advanced hepatocellular carcinoma with HBV infection was withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC) [Phase 2]
Phase 2 clinical trial of RT plus anti-PD-1 therapy for hepatocellular carcinoma is underway; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism [Phase 2]
A Phase 2 randomized open-label study comparing subcutaneous dalteparin to direct oral anticoagulants for cancer-associated venous thromboem…
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating MK-3475 (pembrolizumab) in combination with INCB024360 in various selected cancers; study completed with results …
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: The Safety and Efficacy of Thermal Ablation Combined With Apatinib and Carilimub for Advanced Liver Cancer [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of combining thermal ablation with Apatinib and Carilimub for advanced hepatocellular …
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma [Phase 3]
Phase 3 trial investigating combined radiotherapy and radiofrequency ablation for hepatocellular carcinoma is in early/status-unknown stage.